Mersana Therapeutics (MRSN)
(Delayed Data from NSDQ)
$2.88 USD
-0.33 (-10.28%)
Updated Apr 24, 2024 04:00 PM ET
After-Market: $2.88 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/14/2024
Time: -- |
3/2024 | $-0.18 | 0.00% |
Earnings Summary
For their last quarter, Mersana Therapeutics (MRSN) reported earnings of -$0.16 per share, beating the Zacks Consensus Estimate of $-0.20 per share. This reflects a positive earnings surprise of 20.00%. Look out for MRSN's next earnings release expected on May 14, 2024. For the next earning release, we expect the company to report earnings of -$0.18 per share, reflecting a year-over-year increase of 65.38%.
Earnings History
Price & Consensus
Zacks News for MRSN
Mersana Therapeutics, Inc. (MRSN) Reports Q4 Loss, Lags Revenue Estimates
MRSN: What are Zacks experts saying now?
Zacks Private Portfolio Services